aTyr Pharma Inc. (ATYR)
3.29
-0.67 (-16.81%)
At close: Mar 03, 2025, 3:59 PM
3.40
3.19%
Pre-market: Mar 04, 2025, 04:04 AM EST
aTyr Pharma Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Cash & Equivalents | 22.54M | 9.98M | 2.34M | 16.95M | 9.21M | 22.96M | 21.09M | 38.39M | 53.02M | 13.9M | 36.46M | 3.67M |
| Short-Term Investments | 75.62M | 56.16M | 105.58M | 14.74M | 21.93M | 26.58M | 64.03M | 33.76M | 42.51M | 1.95M | n/a | n/a |
| Long-Term Investments | 3.48M | 3.17M | n/a | n/a | n/a | n/a | n/a | 4M | 29.81M | n/a | n/a | 69K |
| Other Long-Term Assets | 131K | 193K | 158K | 213K | 172K | 90K | 90K | 333K | 118K | 2.21M | 260K | 331K |
| Receivables | 2.44M | 11.78M | 435K | 2.04M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 2.39M | 2.95M | 5.22M | 1.8M | 681K | 1.26M | 1.87M | 2.62M | 2.42M | 656K | 564K | 816K |
| Total Current Assets | 102.99M | 80.87M | 113.57M | 35.53M | 31.93M | 50.8M | 86.98M | 74.77M | 97.95M | 16.51M | 37.02M | 4.49M |
| Property-Plant & Equipment | 14.05M | 11.56M | 1.81M | 2.98M | 4.09M | 1.85M | 2.28M | 1.42M | 1.79M | 1.93M | 2.5M | 2.58M |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 17.66M | 14.91M | 1.97M | 3.19M | 4.26M | 1.94M | 2.37M | 5.76M | 31.73M | 4.13M | 2.77M | 2.98M |
| Total Assets | 120.65M | 95.79M | 115.54M | 38.73M | 36.19M | 52.75M | 89.36M | 80.52M | 129.68M | 20.64M | 39.79M | 7.47M |
| Account Payables | 3.53M | 3.11M | 1.03M | 1.43M | 847K | 1.04M | 2.28M | 2.61M | 3.87M | 1.43M | 1.05M | 593K |
| Deferred Revenue | n/a | n/a | 1.00 | n/a | 208K | n/a | n/a | 130K | n/a | n/a | n/a | 255K |
| Short-Term Debt | 1.33M | 894K | 980K | 861K | 9.49M | 7.77M | 5.01M | 339K | 3.37M | 5.13M | 728K | 875K |
| Other Current Liabilities | 11.56M | 9.86M | 4M | 3.57M | 3.48M | 2.03M | 3.1M | 5.58M | 4.91M | 3.55M | 3.42M | 1.81M |
| Total Current Liabilities | 16.42M | 13.86M | 6.01M | 5.86M | 12.92M | 10.83M | 10.39M | 8.53M | 12.15M | 10.11M | 5.21M | 3.53M |
| Long-Term Debt | 13.77M | 10.64M | 398K | 1.38M | 2.24M | 8.26M | 14.72M | 9.2M | 1.78M | 5.14M | 6.16M | 3.67M |
| Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 701K | 96.4M | 94.5M | 512K |
| Total Long-Term Liabilities | 13.77M | 10.64M | 398K | 1.38M | 2.24M | 8.26M | 14.72M | 9.2M | 2.48M | 101.54M | 100.66M | 5.2M |
| Total Liabilities | 30.18M | 24.5M | 6.41M | 7.24M | 15.16M | 19.1M | 25.11M | 17.72M | 14.63M | 111.65M | 105.87M | 8.73M |
| Total Debt | 15.1M | 11.53M | 1.38M | 2.24M | 11.73M | 16.03M | 19.73M | 9.54M | 5.14M | 10.28M | 6.89M | 4.54M |
| Common Stock | 63K | 29K | 28K | 11K | 4K | 31K | 30K | 24K | 24K | 1K | 1K | 6K |
| Retained Earnings | -468.02M | -417.63M | -372.3M | -338.53M | -322.3M | -298.7M | -264.19M | -215.98M | -158.12M | -110.15M | -85.8M | -64.52M |
| Comprehensive Income | -74K | -433K | -263K | -43K | -40K | -60K | -120K | -76K | -171K | -69K | -69K | n/a |
| Shareholders Equity | 90.66M | 71.46M | 109.3M | 31.65M | 21.19M | 33.65M | 64.25M | 62.8M | 115.05M | -91.01M | -68.5M | -1.28M |
| Total Investments | 79.11M | 59.33M | 105.58M | 14.74M | 21.93M | 26.58M | 64.03M | 37.76M | 72.32M | 1.95M | n/a | 69K |